好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Novel Missense Mutation in the Mitochondrial ND2 Gene in a Patient with Isolated Complex I Deficient Leigh Syndrome
Neurotoxicology
(-)
127
Authors/Disclosures
Sabrina Apel, MD (Peak Medical) No disclosure on file
Hunaid Hasan, MD No disclosure on file
Daniel A. Graf, MD (SMG Neurology Specialists) No disclosure on file
Alok Dabi, MD, MBBS, FAAN (University of Texas Medical Branch) Dr. Dabi has nothing to disclose.
Matthew Senjem (Mayo Clinic) Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.